Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05359991 · ClinicalTrials.gov registry record · NA

Exercise in Child Health

A NA study of Sickle Cell Disease and Cystic Fibrosis, sponsored by University of California, Irvine.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT05359991 is a NA study of Sickle Cell Disease and Cystic Fibrosis that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 240 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05359991, a NA study of Sickle Cell Disease and Cystic Fibrosis, is actively recruiting participants, sponsored by University of California, Irvine.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

This study is a cooperative investigation funded by the NIH. The project is a collaboration among three major NIH Clinical Translational Science Awardees: 1) UCI (lead site with its affiliate CHOC), 2) Northwestern University (with its affiliate Lurie Children's Hospital), and 3) USC (with its affiliate Children's Hospital of Los Angeles). There is an increasing number of children who, through medical advances, now survive diseases and conditions that were once fatal, but which remain chronic and debilitating. A major challenge to improve both the immediate and long term care and health of such children has been the gap in our understanding of how to assess the biological effects of exercise. Like otherwise healthy children, children with chronic diseases and disabilities want to be physically active. The challenge is to determine what constitutes safe and beneficial level of physical activity when the underlying disease or condition \[e.g., cystic fibrosis (CF) or sickle cell disease (SCD)\] imposes physiological constraints on exercise that are not present in otherwise healthy children. Current exercise testing protocols were based on studies of athletes and high performing healthy individuals and were designed to test limits of performance at very high-intensity, unphysiological, maximal effort. These approaches are not optimal for children and adolescents with disease and disability. This project (REACH-Revamping Exercise Assessment in Child Health) is designed to address this gap. Cohorts of children will be identified with two major genetic diseases (CF and SCD) and measure exercise responses annually as they progress from early puberty to mid or late puberty over a 3-4year period. In addition, in the light of the pandemic, a group of children will be added who were affected by SARS-CoV-2 and investigate their responses to exercise. SARS-CoV-2 has similar long-term symptoms than CF and SCD have. Novel approaches to assessing physiological responses to exercis

Interventions

  • OTHER Exercise

Study Locations (1)

California

  • University of California, Irvine - Irvine

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2020-11-12
Est. Completion 2026-01
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT05359991

The ClinicalTrials.gov registry entry for NCT05359991 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (18% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.

NCT05359991 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05359991 about?

NCT05359991 is a clinical study titled "Exercise in Child Health". This study is a cooperative investigation funded by the NIH. The project is a collaboration among three major NIH Clinical Translational Science Awardees: 1) UCI (lead site with its affiliate CHOC), 2) Northwestern University (with its affiliate Lurie Children's Hospital), and 3) USC (with its affil...

What is the current status of trial NCT05359991?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2020-11-12. Estimated completion is 2026-01.

What conditions does trial NCT05359991 study?

This clinical trial studies the following conditions: Sickle Cell Disease, Cystic Fibrosis, SARS CoV 2 Infection.

What interventions are being tested in trial NCT05359991?

The interventions under investigation include: Exercise (OTHER).

Who is sponsoring clinical trial NCT05359991?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05359991 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.